Beneficial Effect of a Mitochondrial-targeted Antioxidant Mitotempo in Insulin-resistant Mammalian Cardiac Dysfunction
Abstract
Objectives: Overfeeding with a high carbohydrate and/or high-fat diet induces metabolic syndrome (MetS) in humans, which is characterized by insulin-resistance. Long life span leads to increases in the ratio of aged humans in populations and an important percentage of the aged humans has insulin-resistance. There is a close relationship between insulin resistance and cardiac dysfunction, at least, via uncontrolled production of reactive oxygen species, while mitochondrial dysfunction plays an important role in that relation. To explore that relation, we aimed to examine the possible cardioprotective effect of a mitochondria-targeting antioxidant by using electrophysiological and histological examinations.
Materials and Methods: We used Wistar male rats in three groups as; those that were 24-month-old (elderly group; n=7), adults fed with 32% sucrose diet (MetS-group; 6-month-old; n=7), and adults fed with standard food (Control group; 6-month-old, n=7). MetS was confirmed with high blood glucose, oral glucose tolerance test, and serum insulin levels. Cardiomyocytes either treated with an antioxidant MitoTEMPO were isolated from the left ventricle by enzymatic method, and the ultrastructure and function of mitochondria as well as adenosine triphosphate (ATP)-dependent K+-channel currents (IKATP; patch-clamp technique) were evaluated.
Results: There were marked increases in the fragmentation of mitochondria, depolarization in the membrane potential, and the production of ROS in insulin-resistant cardiomyocytes. There were significant decreases in IKATP and ATP level (p<0.05) in the aged-cardiomyocytes. Incubation of those insulin-resistant or aged-cardiomyocytes with a mitochondria-targeting antioxidant MitoTEMPO (0.1 μM, 4-5 h at 37°C) provided marked reverses in those parameters.
Conclusion: Overall, the present data strongly indicate that mitochondria-targeting antioxidant application can exert cardioprotective effects in either insulin-resistant MetS or aged mammalians, providing strong implications on mitochondria as a novel strategy for prevention/treatment of cardiovascular diseases.
Keywords
Ageing, Metabolic Syndrome, Insulin Resistance, Cardiac Function, Mitochondria, Antioxidants
Ethical Statement
Etik Kurul Onayı: Etik onayı Ankara Üniversitesi Hayvan Deneyleri Yerel Etik Kurulu’ndan alınmıştır (Karar no: 2016-18-165, tarih: 21.09.2016).
Hasta Onayı: Bu çalışmada bir hayvan deneyi çalışması olduğundan hasta onayı alınmamıştır.
Hakem Değerlendirmesi: Editörler kurulunun dışından olan kişiler tarafından değerlendirilmiştir.
Yazarlık Katkıları
Konsept: B.T., K.C.A., Dizayn: B.T., Veri Toplama veya İşleme: C.V.B., Y.O., D.B., Analiz veya Yorumlama: C.V.B., Y.O., D.B., B.T., K.C.A., Literatür Arama: C.V.B., Y.O., Yazan: B.T.
Çıkar Çatışması: Yazarlar tarafından çıkar çatışması bildirilmemiştir.
Finansal Destek: Bu çalışmanın finansal desteği, TÜBİTAK SBAG-216S979 nolu projeden sağlanmıştır.
References
- 1. Durak A, Bitirim CV, Turan B. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats. Cardiovasc Drugs Ther. 2020;34:487-501.
- 2. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335-344.
- 3. Nickel A, Kohlhaas M, Maack C. Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 2014;73:26-33.
- 4. Lesnefsky EJ, Chen Q, Hoppel CL. Mitochondrial Metabolism in Aging Heart. Circ Res. 2016;118:1593-1611.
- 5. Murphy MP. Understanding and preventing mitochondrial oxidative damage. Biochem Soc Trans. 2016;44:1219-1226.
- 6. Nguyen BY, Ruiz-Velasco A, Bui T, et al. Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials. Br J Pharmacol. 2019;176:4302-4318.
- 7. Bhashyam S, Parikh P, Bolukoglu H, et al. Aging is associated with myocardial insulin resistance and mitochondrial dysfunction. Am J Physiol Heart Circ Physiol.2007;293:3063-3071.
- 8. McMillin JB, Taffet GE, Taegtmeyer H, et al. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc Res. 1993;27:2222-2228.
- 9. Olgar Y, Degirmenci S, Durak A, et al. Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance. Exp Gerontol. 2018;110:172-181.
- 10. Durak A, Olgar Y, Degirmenci S, et al. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats. Cardiovasc Diabetol. 2018;17:144.